Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data
Picket, AndyToxin Science Limited, Wrexham, UK; Botulinum research Center, UMASS Dartmouth, MA, USAModern clinical use of botulinum toxin (BoNT) by doctors requires evidence- based facts and data to support their work. In particular, these need to be unbiased and complete. Too often in the past, spe...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f46c94a934842248ae15ea23865ba92 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|